Clinical trials
Ventricular Dysfunction, Left trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 6 |
| Completed | 3 |
| Not yet recruiting | 3 |
| Recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| Chinese PLA General Hospital | 1 |
| Fifth Affiliated Hospital, Sun Yat-Sen University | 1 |
| Guofeng Gao | 1 |
| Nanjing Medical University | 1 |
| Novartis Pharmaceuticals | 1 |
| Peking University Third Hospital | 1 |
| Shanghai 10th People's Hospital | 1 |
| Shanghai East Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ventricular Dysfunction, Left | 15 |
| Coronary Artery Disease | 5 |
| Heart Failure | 3 |
| Acute Coronary Syndrome | 1 |
| Cardiac Output, Low | 1 |
| Cardiovascular Diseases | 1 |
| Coronary Disease | 1 |
| Diabetes Mellitus | 1 |
| Heart Failure, Systolic | 1 |
| Hypertension, Pulmonary | 1 |
Trials
Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.